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A 75-year-old diabetic man with a cardiac history of pacemak-
er implantation and mechanical prosthetic valve (PV) replace-
ment, also known for chronic osteitis of the first left
metatarsophalangeal joint (MTP I), was treated with oral an-
tibiotic on an outpatient basis with poor compliance when he
developed intermittent fever (39.8 °C) and left foot pain.
Laboratory testing revealed a slight elevation of the white
blood cell count (10.7 G/L) and a significant elevation of the
C-reactive protein (235 mg/L). Hemocultures turned positive
for multi-sensitive Staphylococcus aureus and Proteus
mirabilis. A left foot CT showed MTP I osteoarthritis without
collection. Transoesophageal echocardiography (TOE)
showed no evidence of endocarditis. A double antibiotic reg-
imen was started, but the patient developed persistent fever.
Repeated TOE raised endocarditis suspicion. Because of a
newly developed cough, a search for respiratory pathogens
was performed and turned positive for severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. An 18F-
FDG PET/CT was requested for investigating the suspicion
of PV infection with a 72-h low-carbohydrate diet preparation.
The 18F-FDG PET maximum-intensity projection image
shows (a) bilateral metabolic lung lesions, the foot infection
(*), and one metabolically active draining sentinel lymph node
(arrowhead). (b) Free-breathing lung CT and 18F-FDG with
hypermetabolic (SUVmax 7.6 g/mL) focal ground-glass opaci-
ties with partial consolidation andmild bronchial dilatation with
a peripheral distribution in the subpleural and periscissural re-
gions of the apical and posterior segments of both upper lobes
and right middle lobe, as previously described on CT [1]. (c)
Hypermetabolic lymphadenopathies in the right lower
paratracheal, subcarinal, and bilateral hilar stations (SUVmax
6.1 g/mL). (d, e) Absence of active PVor PM case/lead infec-
tion and no sign of septic embolism. (f) 18F-FDG PET/CT
showing intense FDG accumulation in MTP I compatible with
an active bone infection. (g) Comparison of 18F-FDG activity in
the lung ground-glass opacities vs. the mediastinal, hilar, and
paratracheal lymph nodes.
This case illustrates the benefit of 18F-FDG PET/CT in
differential diagnosis of fever of multiple possible origins in
the setting of SARS-CoV-2 infection [2]. In accordance with
previous retrospective observations [3, 4], we confirmed the
characteristic pattern of SARS-CoV-2 viral infection on 18F-
FDG PET/CT with intense 18F-FDG uptake of pulmonary
lesions, nodal involvement, and absence of other hypermeta-
bolic lesions [3]. To the best of our knowledge, this is the first
prospective case showing the feasibility of 18F-FDG PET/CT
in patients with confirmed SARS-CoV-2 infection when tak-
ing adequate protective measures [5].
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